lifestyle.capitolhilltimes.com

Author: RATHBUN COMMUNICATIONS

Variant Bio Appoints Craig T. Basson, MD, PhD, to Advance Genomics-Driven Clinical Programs

January 21, 2026
Variant Bio Launches Inference, the World’s First Agentic AI Genomic Drug Discovery Platform

January 6, 2026
Variant Bio Announces Strategic Target Discovery Collaboration with Boehringer Ingelheim for Kidney Disease

January 6, 2026